Question 1

Has Neelima Katukuri received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $10,605 in general payments to Neelima Katukuri across 130 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Neelima Katukuri did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Neelima Katukuri come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Edwards Lifesciences	33	$3,450
Abbott	29	$3,100
Penumbra, Inc.	2	$1,096
Abiomed	10	$746
W. L. Gore & Associates, Inc.	19	$728
Boston Scientific	6	$595
AstraZeneca	8	$330
Medtronic(2 entities)	8	$295
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	6	$110
AbbVie	2	$40
Amarin Pharma, Inc.	2	$35
Cook Medical LLC	2	$27
Kestra Medical Technology Services, Inc.	1	$21
Novartis	1	$18
Johnson & Johnson	1	$15

Neelima Katukuri

Payments from drug & device makers

Who reported the general payments

What the payments were tied to

How this compares

Other cardiovascular disease in Worcester